Literature DB >> 24522675

Safety of treatment of obsessive compulsive disorder in pregnancy and puerperium.

Shirin Namouz-Haddad, Irena Nulman.   

Abstract

QUESTION: My patient is 3 weeks postpartum and has experienced repetitive checking and washing of her newborn as a result of obsessive concerns with the newborn's safety. Should I refer her for a psychiatric assessment to rule out obsessive compulsive disorder (OCD) or should I reassure her that her behaviour is normal? ANSWER: Current data suggest that pregnancy and the postpartum period are times of high risk of OCD onset and exacerbation. The presenting symptoms of OCD overlap with normal concerns and behaviour during the perinatal period; however, an undiagnosed or untreated disorder could have adverse consequences for both the mother and her newborn. Therefore, it is strongly recommended that this patient undergo screening and psychiatric assessment in order to be appropriately managed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522675      PMCID: PMC3922556     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  38 in total

1.  SSRIs and persistent pulmonary hypertension of the newborn.

Authors:  Gideon Koren; Hedvig Nordeng
Journal:  BMJ       Date:  2011-01-12

Review 2.  Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies.

Authors:  Mallay Occhiogrosso; Setareh Salehi Omran; Margaret Altemus
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

3.  Distribution and excretion of fluoxetine and norfluoxetine in human milk.

Authors:  J H Kristensen; K F Ilett; L P Hackett; P Yapp; M Paech; E J Begg
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 4.  Anxiety disorders during pregnancy and the postpartum period: A systematic review.

Authors:  Lori E Ross; Linda M McLean
Journal:  J Clin Psychiatry       Date:  2006-08       Impact factor: 4.384

5.  The serotonin hypothesis of obsessive compulsive disorder.

Authors:  L C Barr; W K Goodman; L H Price
Journal:  Int Clin Psychopharmacol       Date:  1993-11       Impact factor: 1.659

Review 6.  Anxiety disorders in pregnancy.

Authors:  Bavanisha Vythilingum
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

7.  Obsessive-compulsive disorder in pregnant women during the third trimester of pregnancy.

Authors:  Faruk Uguz; Kazim Gezginc; Ismet Esra Zeytinci; Savas Karatayli; Rustem Askin; Ozkan Guler; Figen Kir Sahin; H Murat Emul; Omer Ozbulut; Omer Gecici
Journal:  Compr Psychiatry       Date:  2007-07-05       Impact factor: 3.735

Review 8.  Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Authors:  Benjamin Bar-Oz; Thomas Einarson; Adrienne Einarson; Radinka Boskovic; Lisa O'Brien; Heli Malm; Anick Bérard; Gideon Koren
Journal:  Clin Ther       Date:  2007-05       Impact factor: 3.393

9.  Selective serotonin reuptake inhibitors in pregnancy and infant outcomes.

Authors:  Ann L Jefferies
Journal:  Paediatr Child Health       Date:  2011-11       Impact factor: 2.253

10.  Female hormones affect symptom severity in obsessive-compulsive disorder.

Authors:  Nienke C C Vulink; Damiaan Denys; Léonie Bus; Herman G M Westenberg
Journal:  Int Clin Psychopharmacol       Date:  2006-05       Impact factor: 1.659

View more
  2 in total

1.  Association between obsessive-compulsive disorder and obstetrical and neonatal outcomes in the USA: a population-based cohort study.

Authors:  Khalidha Nasiri; Nicholas Czuzoj-Shulman; Haim Arie Abenhaim
Journal:  Arch Womens Ment Health       Date:  2021-05-10       Impact factor: 3.633

2.  Benefits of CBT for OCD in pregnancy.

Authors:  Brittney F Dane; Eric A Storch
Journal:  Can Fam Physician       Date:  2014-05       Impact factor: 3.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.